MacroGenics Inc (MGNX.OQ)

MGNX.OQ on NASDAQ Stock Exchange Global Select Market

33.10USD
26 Jan 2015
Change (% chg)

$0.66 (+2.03%)
Prev Close
$32.44
Open
$32.19
Day's High
$33.18
Day's Low
$32.00
Volume
72,617
Avg. Vol
82,575
52-wk High
$40.22
52-wk Low
$17.33

MGNX.OQ

Chart for MGNX.OQ

About

MacroGenics, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. The Company’s product candidates leverage its fully-integrated capabilities around the discovery, development, and... (more)

Overall

Beta: --
Market Cap(Mil.): $901.67
Shares Outstanding(Mil.): 27.79
Dividend: --
Yield (%): --

Financials

  MGNX.OQ Industry Sector
P/E (TTM): -- 191.97 40.82
EPS (TTM): -0.70 -- --
ROI: -24.41 0.47 18.35
ROE: -29.61 -0.80 19.25
Search Stocks

Competitors

  Price Chg
Roche Holding Ltd. (ROG.VX) CHF255.10 +6.10
Amgen, Inc. (AMGN.OQ) $159.73 -0.08
Xencor Inc (XNCR.OQ) $17.48 +0.07

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks